Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mfglola's Profile
Displaying 1-50 of 101 result(s).
CYDY CytoDyn Inc
10/02/2025 7:50:01 PM
Went to the websites of each of our (5)
CYDY CytoDyn Inc
10/01/2025 1:13:59 PM
the two Ph.D.s covering this are pr (1)
CYDY CytoDyn Inc
09/29/2025 10:21:50 PM
From our AACR abstract... Conclusio (4)
CYDY CytoDyn Inc
09/29/2025 10:04:14 PM
Ok. I thought "follow-up study" was (1)
CYDY CytoDyn Inc
09/29/2025 9:23:02 PM
It was obviously turned down by th (5)
CYDY CytoDyn Inc
09/11/2025 6:11:32 AM
"Patients completing study CD-O-101 (7)
CYDY CytoDyn Inc
09/10/2025 9:55:30 PM
My complaint is that patients only (5)
CYDY CytoDyn Inc
09/09/2025 11:04:39 PM
France Grants Reimbursed Compassion
CYDY CytoDyn Inc
09/05/2025 9:01:24 AM
Perhaps the enemy of my enemy is m (1)
CYDY CytoDyn Inc
09/04/2025 9:07:08 PM
We made up with Pestell, why not BP (5)
CYDY CytoDyn Inc
07/25/2025 5:47:03 PM
"given the encouraging results desc (5)
CYDY CytoDyn Inc
07/25/2025 3:55:28 PM
A Cornell Alzheimer's study... "Thi (6)
CYDY CytoDyn Inc
07/23/2025 9:11:09 PM
So FDA is now accepting application (8)
CYDY CytoDyn Inc
07/04/2025 8:49:15 AM
INmune Bio's TNF inhibitor targetin (3)
CYDY CytoDyn Inc
07/03/2025 6:57:19 PM
AstraZeneca contemplating a $15B li (13)
CYDY CytoDyn Inc
07/03/2025 1:40:53 PM
Dr. Weinberg had an oral presentati (5)
CYDY CytoDyn Inc
07/01/2025 1:45:39 PM
DSP107 + atezolizumab in 3L MSS crc (3)
CYDY CytoDyn Inc
07/01/2025 12:00:46 PM
In addition to its potential as a â (3)
CYDY CytoDyn Inc
07/01/2025 12:16:58 AM
I'm thinking, even if we doubled it (7)
CYDY CytoDyn Inc
06/05/2025 10:37:00 AM
"Pharma companies rush in to buy wh (11)
CYDY CytoDyn Inc
06/04/2025 10:49:28 PM
prostate cancer is now in stage pre (5)
CYDY CytoDyn Inc
06/02/2025 7:49:19 PM
Merck won't partner with Gilead in (2)
CYDY CytoDyn Inc
06/02/2025 3:56:59 PM
Overall Survival and Quality-of-Lif (8)
CYDY CytoDyn Inc
06/02/2025 3:43:18 PM
Sorry, I don't know how to post an (13)
CYDY CytoDyn Inc
06/02/2025 3:31:44 PM
Came across this on X. Let's hope s (1)
CYDY CytoDyn Inc
05/19/2025 12:21:27 PM
Yes, the FDA has accepted PD-L1 as (9)
CYDY CytoDyn Inc
05/17/2025 6:31:38 PM
I don't know if an ICI will ever b
CYDY CytoDyn Inc
05/16/2025 11:51:40 AM
"Upregulation of PD-L1 was seen in (7)
CYDY CytoDyn Inc
05/15/2025 9:09:22 AM
I am completely baffled as to how m (3)
CYDY CytoDyn Inc
05/13/2025 11:45:22 PM
I'm more focused on Roche, which ha (7)
CYDY CytoDyn Inc
05/02/2025 7:03:01 AM
the "50% survival level"...DIDN'T E (2)
CYDY CytoDyn Inc
04/24/2025 9:15:10 AM
What is Gilead's hope/intention by (4)
CYDY CytoDyn Inc
04/10/2025 7:36:14 PM
If not, are there other types of br (2)
CYDY CytoDyn Inc
03/26/2025 9:46:30 AM
The trial you linked must have used (2)
CYDY CytoDyn Inc
03/13/2025 10:08:08 AM
The hidden scars of ulcerative coli (10)
CYDY CytoDyn Inc
02/27/2025 3:53:01 PM
I see Dr. P will be on Steve Kirsch (4)
CYDY CytoDyn Inc
02/22/2025 5:54:11 PM
A discovery at Duke-NUS Medical Sch (14)
CYDY CytoDyn Inc
02/12/2025 11:01:01 PM
maraviroc is now a generic drug , n
CYDY CytoDyn Inc
01/27/2025 8:59:51 PM
I haven't ran across any studies lo (8)
CYDY CytoDyn Inc
01/27/2025 8:32:33 AM
Agenus' botensilimab/balstilimab co (4)
CYDY CytoDyn Inc
01/10/2025 8:39:05 AM
Mediar Therapeutics Enters into Glo (7)
CYDY CytoDyn Inc
01/08/2025 6:16:03 PM
Calico’s fosigotifator was tested (4)
CYDY CytoDyn Inc
12/15/2024 1:39:02 PM
Maybe I missed it, but I don't reme (3)
CYDY CytoDyn Inc
12/12/2024 7:41:59 PM
I'm sure he's very aware of the sto (3)
CYDY CytoDyn Inc
12/09/2024 8:45:57 AM
And playing six degrees of leronlim (8)
CYDY CytoDyn Inc
12/06/2024 8:09:36 PM
Maybe it is the Gates Foundation th (14)
CYDY CytoDyn Inc
11/22/2024 3:39:58 PM
The dosing schedule should be and t (2)
CYDY CytoDyn Inc
11/14/2024 11:26:32 PM
I think someone (Ohm?) should make (3)
CYDY CytoDyn Inc
11/13/2024 2:34:34 PM
Upregulation of CCL4 after treatmen (6)
CYDY CytoDyn Inc
11/05/2024 6:59:00 AM
Surrogate reads like anecdotal is b (4)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Landsbankinn Strengthens Market Position with New Agreements
  • Teladoc Health's Growth Drives Stock Surge on New Insights
  • Rumble Inc. Partners with Perplexity to Enhance Video Discovery
  • Legal Update: Investors Urged to Act Before KinderCare Deadline
  • Investing in Keysight Technologies: A Decade of Growth
  • Key Updates on CTO Class Action: Understanding Investor Rights
  • Apple App Store Sees 10% Revenue Growth Amid AI Surge
  • Impact of Recent Shutdowns on Market Sentiments and Trends
  • Investigation on Behalf of Jasper Therapeutics Investors Unfolds
  • Jeanette Weinz Rises as a Leading Force in Franchise Success
  • Investors Alert: Unicycive Therapeutics Faces Legal Investigation
  • MemorialCare Independent Physicians: Transforming Healthcare Delivery
  • Accountants Break Barriers with Record-Breaking Event
  • Investigation into Hims & Hers' Board Conduct Explores Fiduciary Duties
  • Sienna Senior Living Set to Share Q3 Results and Insights
  • Sysco Champions Culinary Excellence at Southern Smoke Festival
  • Mesa Laboratories Announces Exciting Quarterly Dividend Updates
  • Middlefield Canadian Income PCC Reports Estimated NAV Gains
  • HighCo's Shareholding Update: Key Voting Rights Insights
  • Goodwill NYNJ Launches Empowering Career Program in Queens
  • Israeli Tech Sector Experiences Massive M&A Surge in 2025
  • Beth Gerstein's Tribute to Dr. Jane Goodall's Legacy
  • Investigation Targets Companies for Shareholder Rights Violations
  • Unlocking the Growth: Investing in Booking Holdings' Stock
  • TD Securities Adjusts BlackBerry Ratings Amid QNX Growth
  • Investigation of Companies STAA, BTBD, and CIO for Shareholders
  • Halper Sadeh LLC Investigates Electronic Arts and More
  • Solarea Bio Welcomes New Executive Leadership for Growth
  • UNISORB to Present Innovative Installation Solutions at MT Southeast
  • Explore the Exquisite Downton Abbey Jewelry Collection with REEDS
  • Insider Transactions Highlight Molina Healthcare's Future Potential
  • Avobis Bio's AVB-114 Gains RMAT Designation for Chronic Condition
  • Richard M Schapiro's $54K Molina Healthcare Investment Insight
  • Molina Healthcare Insider Purchase Signals Positive Outlook
  • Investigation Into MoonLake Immunotherapeutics: A Closer Look
  • Teamsters Strike for Fair Wages at Brulin Holding Company
  • Molina Healthcare's Director Shares His Confidence With Stock Purchase
  • Molina Healthcare Insider Key Moves and Market Insights
  • Molina Healthcare Insider Purchases $54K Worth of Shares
  • Barbara L Brasier Invests $54K in Molina Healthcare Shares
  • Class Action Suit for Altimmune Investors: Key Updates Inside
  • Classover Holdings Embraces Solana for Future Growth
  • Bitcoin Soars to $121,000: Insights for the Crypto Market
  • Surge in Quantum Stocks: Opportunities and Insights Ahead
  • Insights into NVIDIA's Position Against Semiconductor Rivals
  • Examining Microsoft’s Position Among Leading Software Firms
  • Evaluating Meta Platforms Amidst Rivals in Media Services
  • In-Depth Competitor Assessment of Amazon in Retail Market
  • Exploring BlackRock's Performance Through P/E Ratio Analysis
  • Comparing Apple’s Performance Against Tech Hardware Rivals
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site